Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
The Lancet. HIV|April 15, 2018
Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trialJane Mallewa, Alexander J Szubert, Peter Mugyenyi, et al.
Contemporary Clinical Trials|January 9, 2026
Trial design and enrolment characteristics of LATA (long-acting treatment in adolescents): A randomised, open-label, non-inferiority, 96-week trial evaluating the virological efficacy, safety, acceptability and quality-of-life of the dual long-acting injectable regimen cabotegravir/ rilpivirine compared to daily oral therapy in virologically suppressed adolescents with HIV-1 infection, aged 12 to <20 years, in Sub-Saharan AfricaDiana Anena, Elizabeth Chappell, Rashidah Nazzinda, et al.
The Lancet. Psychiatry|June 29, 2020
Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance studyAravinthan Varatharaj, Naomi Thomas, Mark A Ellul, et al.
AIDS (London, England)|May 31, 2024
MAVMET trial: maraviroc and/or metformin for metabolic dysfunction associated fatty liver disease in adults with suppressed HIVLeanne McCabe, James E Burns, Arash Latifoltojar, et al.
The Lancet. HIV|April 10, 2026
Efficacy and safety of short-cycle, dolutegravir-based antiretroviral therapy in adolescents living with HIV (BREATHER Plus): a multicentre, open-label, randomised, parallel, two-arm, non-inferiority trialAdeodata R Kekitiinwa, Angus Jennings, Mutsa Bwakura-Dangarembizi, et al.
Open Forum Infectious Diseases|August 2, 2021
High Cure Rates for Hepatitis C Virus Genotype 6 in Advanced Liver Fibrosis With 12 Weeks Sofosbuvir and Daclatasvir: The Vietnam SEARCH StudyBarnaby Flower, Leanne McCabe, Chau Le Ngoc, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 20, 2024
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19Neil R Aggarwal, Jacquie Nordwall, Dominique L Braun, et al.
Elife|January 9, 2023
Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for hepatitis C in a single-arm mechanistic pilot studyBarnaby Flower, Le Manh Hung, Leanne Mccabe, et al.
Lancet (London, England)|May 10, 2025
Treatment options to support the elimination of hepatitis C: an open-label, factorial, randomised controlled non-inferiority trialGraham S Cooke, Le Manh Hung, Barnaby Flower, et al.
Scientific Reports|March 22, 2025
SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial)Sofía Sábato, Susana Benet, Angela J Rogers, et al.
Pageof 6